Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 19/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5803224 | 0.92 | DPP4 (0.41) | DPP4DPP8DPP9 | |
| SCHEMBL5739431 | 0.85 | DPP4 (0.49) | DPP4DPP8DPP9 | |
| SCHEMBL5454913 | 0.84 | DPP4 (0.46) | DPP4DPP8DPP9NPC1RAB9A | |
| SCHEMBL5740063 | 0.84 | DPP4 (0.53) | DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL5449121 | 0.83 | DPP4 (0.58) | DPP4DPP8DPP9 | |
| SCHEMBL5239400 | 0.78 | DPP4 (0.54) | DPP4DPP8DPP9 | |
| SCHEMBL5782244 | 0.78 | DPP4 (0.53) | DPP4DPP8DPP9 | |
| SCHEMBL5740441 | 0.78 | DPP4 (0.64) | DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL27665018 | 0.77 | DPP4 (0.50) | DPP4DPP8DPP9 | |
| SCHEMBL5454446 | 0.77 | DPP4 (0.54) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678138-A1 | PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | Takeda Pharmaceutical Company Limited (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042488-A1 | PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-12 | — | — | WO | disclosed |